Seger's LAP IA 60TM is the first easy-to-use
closure device that enables
100% laparoscopic anastomosis.


SEGER Surgical Solutions was chosen to represent the Society of Surgery of the Alimentary Tract (SSAT) in the 2023 DDW Shark Tank on May 7, 2023.
See you there!

About Us

Seger Surgical Solutions is developing the first easy-to-use closure device that enables 100% laparoscopic anastomosis.

Seger was founded in Israel in 2017. A portfolio company of The Trendlines Group, Seger is located in the Misgav Industrial Park in Israel’s Western Galilee.

Seger’s Novel Solution – LAP IATM

Bowel resection surgery involves removing all or part of the intestine. After resection, the surgeon creates a common opening in the two bowel sections to connect them (anastomosis).

Laparoscopic bowel resection and anastomosis is preferred over open surgery because of its clinical benefits to the patient. At present, the majority of these resections and anastomoses are performed outside the abdomen (extracorporeal). The reason for this is the difficulty and complexity of laparoscopic suturing by surgeons.

Seger Surgical Solutions introduces LAP IA 60, a laparoscopic bowel closure device that quickly and securely aligns, closes, and staples the common opening to allow for intracorporeal anastomosis --without the need for suturing.

The device works with a standard 12-millimeter trocar.

With Seger’s LAP IA 60, laparoscopic bowel resection is now 100% laparoscopic!

The LAP IA 60 improves patient care, provides better outcomes, and reduces health care costs.
Improves Patient Care
  • Fewer surgical site infections (SSIs)
  • Fewer incisional hernias
  • Smaller incisions, more cosmetically placed
Results in Better Outcomes
  • Requires smaller incisions
  • Eliminates risk of bowel twisting
  • Reduces need for additional surgery
Cuts Health Care Costs
  • Reduces procedure time
  • Reduces post-op complications
  • Shortens length of stay (LOS)

Our Team

Shahar Millis

B.Sc., MBA with more than 19 years’ experience in medical device management and R&D, CEO of Fidmi Medical (GI), experience in cardiovascular and gastrointestinal, leading product development from concept to market.

Prof. Barry Salky
Co-Founder & Medical President

Recognized worldwide pioneer and key opinion leader in the laparoscopic surgery field, developed techniques now considered standard of practice; founder, Laparoscopic Surgery Division, Mount Sinai Hospital, NYC; former VP, SAGES; president, International Federation of Surgical Endoscopic Societies (IFSES)

Leo R. Mindick
Co-Founder & Investor

Founder and CEO, Med-Tech Consultant Partners; years of experience in specialty medical devices, IP, regulatory, reimbursement; founder and former CEO, multimillion-dollar specialty medical distribution company (later acquired)

David Hazzan,MD
Clinical Director

Department Chief, Surgery B, Carmel Medical Center, Israel; responsible for preclinical and clinical trials

Surgical Advisory Board

Ho-Seong Han, MD, PhD
Chairman, Department of Surgery; Professor of Surgery (HBP)

Seoul National University
Seoul, Korea

Antonio M. Lacy, MD
Chief, Department of Gastrointestinal Surgery

University of Barcelona; Founder, AIS Channel
Barcelona, Spain

Junji Okuda, MD
Professor; Chief, Colorectal Surgery; Chief, Innovation Unit

Osaka Medical University
Osaka, Japan

Armando Melani, MD
Director: IRCAD America Latina Colorectal Surgeon

Americas Medical City
Rio de Janeiro, Brazil

Alessio Pigazzi, MD, PhD
Chief, Division of Surgical Oncology; Professor of Surgery

University of California Irvine
Irvine, CA, USA

Natan Zundel, MD
Professor of Surgery, Vice Chair, Dept. of Surgery

Herbert Wertheim College of Medicine
Miami, FL, USA


Misgav Business Park, 17 T’chelet St. 20174, Israel


Tel: +972.72.260.7157


Fax: +972.72.260.7257


    Accessibility Toolbar